FDA proposes quick response for 510(k) apps; Study: More than 1 in 7 TAVR patients suffer complications;

 @FierceMedDev: Roche Holdings' heart attack test helped reduce emergency room diagnoses in a new stud--via BloombergReport | Follow @FierceMedDev

 @MarkHFierce: Think an epipen, but shaped like a credit card that offers voice and written instructions. Sanofi made; FDA approved. More | Follow @MarkHFierce

 @DamianFierce: More M&A for Teleflex, this time spending $276M on Singapore's LMA. News | Follow @DamianFierce

> The FDA's proposed 510(k) guidance guarantees that devicemakers will get a response on their applications within 15 days. If the agency fails to do so, the application is automatically accepted for a substantive review. Report

> More than one in 7 patients undergoing transcatheter aortic valve replacement procedures reported major vascular complications, a study reports. News

> China's Dehaier Medical Systems reported flat income growth in Q2, netting $1.7 million on $7 million in revenue. Release

> Medical device manufacturer Helix Medical has acquired a 50% stake in Ireland's Cambus Medical, a maker of catheter components. Story

> Derma Sciences posted a net lost of $2.8 million in the second quarter, up from last year's $551,295, but the company saw its net sales jump 10.9% to $17.6 million. Item

> Medical Compression Systems, an Israeli firm developing a device to prevent blood clots after orthopedic surgery, snagged a $2.5 million investment from Pontifax. Article

Biotech News

 @FierceBiotech: On eve of Forest proxy showdown, Icahn takes aim at management for undisclosed FDA warning letters. Article | Follow @FierceBiotech

 @JohnCFierce: Booming Shire closes in on new campus site for U.S. HQ. More | Follow @JohnCFierce

 @RyanMFierce: Quintiles, the big CRO, gets bigger via buyout of DNA sequencing and analysis shop Expression Analysis. News | Follow @RyanMFierce

> Genentech whistleblower suit claims execs dangerously rushed Pi3K study. Report

> Unconventional Kineta adds to its bankroll for autoimmune program. Story

Pharma News

 @FiercePharma: Merck KGaA's Rebif (for MS) and Erbitux (cancer) helped push Q2 sales past expectations. Weak euro helped, too. More | Follow @FiercePharma

> Icahn slams Forest for undisclosed FDA warning. News

> What are Avastin's chances in its next NICE review? More

> Pfizer, AstraZeneca strike $250M-plus deal for OTC Nexium. Article

Biotech Research News

> Gene offers tantalizing leukemia target. Story

> University of Cambridge debuts latest stem cell research institute. More

> Nanomaterial propels self-repair for damaged hearts. Article

Pharma Manufacturing News

> Internet drug dealer gets 10 years but feds want his Chinese boss. Story

> FTC says GPhA drug shortage plan avoids antitrust issues. More

> FDA asks Merck to make up for Sanofi cancer drug shortage. News

> Thieves target pharmacies, not trucks, in Mexico. Item

> More drugs for U.S. to come from Ranbaxy's Mohali, India, plant. Article

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.